Human Centered Design Approach to GenAI for Life Sciences

Home / Intelligence / Webinars / Human Centered Design Approach to GenAI for Life Sciences

Available On Demand

We need to think through not just whether GenAI works, but how we make it usable for people and impactful for our business…

The next webinar in our “Making AI Real” webinar series will focus on people, process and technology—three interconnected components that are key to successful GenAI implementation.

Join Trinity Life Sciences’ GenAI experts for actionable takeaways about ​​what you should be doing now in these three areas to position your company for success. We will also get “hands on” with real life examples about what good GenAI design looks like to help instill confidence in its use.

Whether you are figuring out the AI strategy for your company or looking to ensure your company (and you) stay ahead of the curve, this webinar is designed for you.

In Case You Missed It

Watch the first two webinars in our “Making AI Real” webinar series:

Unlock the Potential of Generative AI in Insights and Operations

Making AI Real in Medical Affairs


Featuring


Complete the form below to view the on-demand webinar.

By submitting this form, creating an account, and/or using our website (or using our Services) you agree to our Privacy Policy. Information provided by you is stored in our database and may be used for sending you additional information about Trinity (including Trinity’s partners and affiliates) and our products and services. Such information may be transferred for this purpose to Trinity and affiliates in other countries. If you would like to opt out in the future, please email _compliance@trinitylifesciences.com.

This webinar will be hosted within the ON24 platform, which requires the usage of Javascript and Cookies. Please see ON24’s Privacy Policy for more information.

*Gartner, Hype Cycle for Life Sciences Commercial Operations, Animesh Gandhi, published 13 August 2024.

GARTNER is a registered trademark and service mark of Gartner and Hype Cycle is a registered trademark of Gartner, Inc. and/or its affiliates in the U.S. and internationally and are used herein with permission. All rights reserved.

Gartner does not endorse any vendor, product or service depicted in its research publications, and does not advise technology users to select only those vendors with the highest ratings or other designation. Gartner research publications consist of the opinions of Gartner’s research organization and should not be construed as statements of fact. Gartner disclaims all warranties, expressed or implied, with respect to this research, including any warranties of merchantability or fitness for a particular purpose.

Related Intelligence

Analyst Reports

Everest Group recognizes Trinity Life Sciences as a Featured Specialist in Operationalizing Generative AI in Life Sciences

Everest Group report: AI-deas to Action: Operationalizing Generative AI in Life Sciences This research report provides a comprehensive analysis of how generative AI (GenAI) is being operationalized in the life sciences industry and assesses the capabilities of the fifteen vendors included. The report highlights several of Trinity’s key strengths, including: Life Sciences Industry Expertise Trinity […]

 Read More

Webinars

Generative AI in Pharma – Five Years From Now

Available On Demand

Generative AI is having a transformative impact on the pharmaceutical industry. Drugmakers are partnering up with companies like Insilico Medicine, Exscientia, BenevolentAI, and more to leverage their respective generative AI-powered platforms and applying them across the pharma value chain: from accelerating drug discovery and optimizing clinical trials, to improving operational efficiencies and enabling personalized treatments […]

 Watch Now

Webinars

The Future of Patient Finding

Available On Demand

Patient finding is more than a buzzword. Ready to challenge the status quo? With more data, advancements in AIML and greater access to insights, it is not surprising that patient finding is evolving. Many pharma organizations have deep-rooted ideas about what patient finding requires, but they often miss the opportunity to put the patient at […]

 Watch Now